新生血管性眼高压谱系:新生血管性青光眼的新型分类
该文提出一种基于解剖的新生血管性眼高压(NVOH)谱系分类,替代传统「新生血管性青光眼」术语。分类按房角状态分为pre-NVOH、presumed NVOH、NVOH、部分新生血管性房角关闭(NVAC)和完全NVAC五期,并以活动性/静止性作为疾病修饰因子,引入急性新生血管危象(ANC)描述伴症状性眼压急性升高的活动性部分或完全NVAC。该框架强调虹膜角膜角解剖和周边前粘连(PAS)范围对治疗选择的决定作用。
要点
- 以房角状态为核心,将传统NVG分为pre-NVOH至完全NVAC共五期。
- 活动性/静止性反映抗VEGF后眼前段新生血管的存在或消退。
- ANC指伴症状性眼压急性升高的活动性部分或完全NVAC。
核心结论
- NVOH谱系提供了一种解剖学基础的分类,替代含义模糊的「新生血管性青光眼」术语。
- 该分类优先考虑房角状态和疾病活动性而非视神经评估,后者在晚期视网膜疾病眼中常不可靠。
- 该分类支持更精确的诊断、个体化治疗选择和跨学科沟通。
研究设计与样本
- 本文为观点与概念框架类文章,非研究设计,无受试者或对照。
- 作者综合当代临床经验与已发表文献,围绕眼前段新生血管合并眼压升高的诊断与管理构建分类。
- 分类系统基于就诊时虹膜角膜角解剖、周边前粘连(PAS)范围及抗VEGF治疗后的疾病活动性制定。
主要发现
- 提出NVOH谱系,由轻至重依次为pre-NVOH、presumed NVOH、NVOH、部分新生血管性房角关闭(NVAC)和完全NVAC。
- 疾病修饰因子为活动性与静止性,反映抗VEGF治疗后眼前段新生血管的存在或消退。
- 引入急性新生血管危象(ANC)描述伴症状性眼压急性升高的活动性部分或完全NVAC。
- 分类强调粘连性房角关闭范围是管理的关键决定因素,区分抗VEGF后达到静止期可考虑房角微创青光眼手术的眼与需紧急手术降眼压的眼。
关键数值与推荐
- 分期依据就诊时房角状态,由轻至重为pre-NVOH、presumed NVOH、NVOH、部分NVAC和完全NVAC。
- 疾病活动性分为活动性与静止性,以抗VEGF后眼前段新生血管存在或消退判定。
- ANC定义为伴症状性眼压急性升高的活动性部分或完全NVAC。
临床怎么用
- 临床应以房角状态和疾病活动性为核心评估传统所谓NVG眼,而非依赖视神经评估。
- 对达到静止期且房角粘连范围有限者,可考虑房角微创青光眼手术。
- 对活动性部分或完全NVAC伴症状性眼压急性升高(ANC)者,需紧急手术降眼压。
局限性
- 该框架为概念性,缺乏前瞻性验证。
- 需前瞻性研究验证命名、细化分期特异性治疗算法并评估对临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To propose a novel, anatomically based classification system for eyes traditionally labeled as neovascular glaucoma (NVG) that better reflects disease severity, guides contemporary management, and aligns with modern anti-vascular endothelial growth factor (anti-VEGF) and angle-based surgical treatment paradigms. DESIGN: Perspective and conceptual framework. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Not applicable. METHODS, INTERVENTION, OR TESTING: We synthesized contemporary clinical experience and published literature regarding the diagnosis and management of eyes with anterior segment neovascularization and elevated intraocular pressure (IOP). Emphasis was placed on iridocorneal angle anatomy, extent of peripheral anterior synechiae (PAS), disease activity in response to anti-VEGF therapy, and implications for medical and surgical management. Based on these considerations, we developed a staged classification system prioritizing angle status at the time of presentation. MAIN OUTCOME MEASURES: Development of a clinically intuitive, anatomically descriptive nomenclature to categorize disease severity, facilitate communication among clinicians, and support stage-specific treatment protocols. RESULTS: We propose the neovascular ocular hypertension (NVOH) spectrum, consisting of four stages arranged from least to most severe: pre-NVOH, presumed NVOH, NVOH, partial neovascular angle closure (NVAC), and total NVAC. Disease modifiers of active versus quiescent reflect the presence or regression of anterior segment neovascularization following anti-VEGF therapy. The framework also introduces the term acute neovascular crisis (ANC) to describe symptomatic, acutely elevated IOP associated with active partial or total NVAC. This classification emphasizes the extent of synechial angle closure as a key determinant of management, distinguishing eyes that may be candidates for angle-based microinvasive glaucoma surgery, after achieving quiescence, from those requiring urgent surgical IOP lowering. Limitations include the conceptual nature of the framework and the absence of prospective validation. CONCLUSIONS: The NVOH spectrum offers a modernized, anatomically grounded alternative to the ambiguous term "neovascular glaucoma." By prioritizing angle status and disease activity over optic nerve assessment, which is often unreliable in eyes with advanced retinal disease, this classification supports more precise diagnosis, tailored treatment selection, and improved interdisciplinary communication. Prospective studies are needed to validate this nomenclature, refine stage-specific treatment algorithms, and assess its impact on clinical outcomes.
引用
- Swaminathan SS, Qiu M. The Neovascular Ocular Hypertension Spectrum: A Novel Classification of Neovascular Glaucoma. Am J Ophthalmol. 2026. PMID: 42173189. doi:10.1016/j.ajo.2026.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。